{
    "clinical_study": {
        "@rank": "57060", 
        "biospec_descr": {
            "textblock": "peripheral blood"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The investigators hypothesize that the age-adjusted telomere length in lung cancer patients\n      before chemotherapy may be correlated to comorbidity status and predict outcome. The change\n      of telomere length shortening after chemotherapy may relate to treatment side effect and\n      treatment response."
        }, 
        "brief_title": "The Roles of Age, Comorbidity, and Telomere Length in Lung Cancer Treatment and Prognosis", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Lung Cancer", 
        "condition_browse": {
            "mesh_term": "Lung Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Except chemotherapy, telomere shortening were also related to a variety of cellular stress,\n      including hydrogen peroxide, UV, and x-irradiation, transforming growth factor-beta,\n      overexpression of oncogenes such as Ha-Ras. The cellular stress induced telomere shortening\n      and/or telomere dysfunction and promote accelerated senescence in normal and malignant\n      cells. Oxidative stress, which presented in several chronic inflammatory diseases, such as\n      atherosclerosis, coronary artery disease, and chronic obstructive airway disease, was also\n      found to be correlated with telomere shortening."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients who are newly diagnosed as lung cancer and prepared for scheduled\n             chemotherapy.\n\n          2. The diagnosis is based on pathology via surgical specimen, or biopsy; or cytology via\n             lung, lymph node aspiration or effusion study.\n\n        Exclusion criteria:\n\n        includes clinical diagnosis of lung cancer without pathology or cytology proving, combined\n        with other type malignancy, and expected short survival time less than one month."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients who are newly diagnosed as lung cancer and prepared for scheduled chemotherapy in\n        National Taiwan University Hospital will be enrolled for screening. The diagnosis is based\n        on pathology via surgical specimen, or biopsy; or cytology via lung, lymph node aspiration\n        or effusion study."
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01963533", 
            "org_study_id": "201207006RIC"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "lung cancer", 
            "telomere length", 
            "comorbidity", 
            "Eastern Cooperation Oncology Group (ECOG)", 
            "chemotherapy"
        ], 
        "lastchanged_date": "October 16, 2013", 
        "location": {
            "contact": {
                "email": "tuff.chen@msa.hinet.net", 
                "last_name": "Kuan-Yu Chen, PHD", 
                "phone": "886-972651046"
            }, 
            "contact_backup": {
                "email": "chiyohsu@yahoo.com.tw", 
                "last_name": "Chien-Tai Hsu", 
                "phone": "886-223123456", 
                "phone_ext": "67779"
            }, 
            "facility": {
                "address": {
                    "city": "Taipei City", 
                    "country": "Taiwan", 
                    "zip": "100"
                }, 
                "name": "National Taiwan University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_groups": "1", 
        "official_title": "The Roles of Age, Comorbidity, and Telomere Length in Lung Cancer Treatment and Prognosis", 
        "overall_contact": {
            "email": "clhsu7@ntu.edu.tw", 
            "last_name": "Chia-Lin Hsu", 
            "phone": "886-972651890"
        }, 
        "overall_contact_backup": {
            "email": "chiyohsu@yahoo.com.tw", 
            "last_name": "Chien-Tai Hsu", 
            "phone": "886-2-23123456", 
            "phone_ext": "67779"
        }, 
        "overall_official": {
            "affiliation": "NTUH", 
            "last_name": "Kuan-Yu Chen, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Taiwan: Department of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The clinical data, including age, gender, clinical presentation, performance status, disease stage at diagnosis, initial treatment modality, progression-free survival of initial treatment, and survival duration will be recorded.  Blood sample collection, quality of life, and cognitive function assessment will be performed before chemotherapy, one and four weeks after initial chemotherapy for telomere length measurement. Telomere length is measured by quantitative polymerase chain reaction(qPCR). Patients' characteristics are compared with chi-square test. Progression-free survival and survival time are analyzed by Kaplan-Meier with log rank test.", 
            "measure": "The correlation between telomere length shortening and cancer treatment outcome", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01963533"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Taiwan University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Taiwan University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}